While Calumet Inc has underperformed by -7.28%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CLMT rose by 10.60%, with highs and lows ranging from $25.29 to $9.97, whereas the simple moving average fell by -4.96% in the last 200 days.
On February 04, 2025, UBS Downgraded Calumet Inc (NASDAQ: CLMT) to Sell. A report published by TD Cowen on November 11, 2024, Reiterated its previous ‘Buy’ rating for CLMT. TD Cowen also reiterated CLMT shares as ‘Buy’, quoting a target price of $27 on the company’s shares in a report dated October 17, 2024. TD Cowen Reiterated the rating as Buy on August 12, 2024, but set its price target from $20 to $18. Goldman August 18, 2022d its ‘Neutral’ rating to ‘Buy’ for CLMT, as published in its report on August 18, 2022. Cowen’s report from February 28, 2022 suggests a price prediction of $20 for CLMT shares, giving the stock a ‘Outperform’ rating. Credit Suisse also rated the stock as ‘Neutral’.
Analysis of Calumet Inc (CLMT)
Further, the quarter-over-quarter decrease in sales is -4.26%, showing a negative trend in the upcoming months.
One of the most important indicators of Calumet Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. Taking into account the quick ratio of the company, currently set at 0.30, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and CLMT is recording 971.88K average volume. On a monthly basis, the volatility of the stock is set at 8.79%, whereas on a weekly basis, it is put at 10.39%, with a gain of 13.29% over the past seven days. Furthermore, long-term investors anticipate a median target price of $26.10, showing growth from the present price of $17.00, which can serve as yet another indication of whether CLMT is worth investing in or should be passed over.
How Do You Analyze Calumet Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 19.82%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 35.32% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
CLMT shares are owned by institutional investors to the tune of 35.32% at present.
